The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?

Currently, our world is facing the 2019 Novel Coronavirus (COVID-19) outbreak and tremendous efforts are made for developing drugs to treat and vaccines to prevent the disease. At present, there is no specific antiviral drug or vaccine for COVID-19. The pathogenic infectivity of the virus requires t...

Descripción completa

Detalles Bibliográficos
Autores principales: Belen-Apak, F.B., Sarialioglu, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169882/
https://www.ncbi.nlm.nih.gov/pubmed/32335456
http://dx.doi.org/10.1016/j.mehy.2020.109743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169882/
https://www.ncbi.nlm.nih.gov/pubmed/32335456
http://dx.doi.org/10.1016/j.mehy.2020.109743

Ejemplares similares